1. Home
  2. VRME vs INDP Comparison

VRME vs INDP Comparison

Compare VRME & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • INDP
  • Stock Information
  • Founded
  • VRME 1999
  • INDP 2000
  • Country
  • VRME United States
  • INDP United States
  • Employees
  • VRME N/A
  • INDP N/A
  • Industry
  • VRME EDP Services
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRME Technology
  • INDP Health Care
  • Exchange
  • VRME Nasdaq
  • INDP Nasdaq
  • Market Cap
  • VRME 14.5M
  • INDP 15.4M
  • IPO Year
  • VRME N/A
  • INDP N/A
  • Fundamental
  • Price
  • VRME $1.36
  • INDP $1.12
  • Analyst Decision
  • VRME Buy
  • INDP Strong Buy
  • Analyst Count
  • VRME 1
  • INDP 1
  • Target Price
  • VRME $1.50
  • INDP $12.00
  • AVG Volume (30 Days)
  • VRME 15.1K
  • INDP 20.4K
  • Earning Date
  • VRME 11-06-2024
  • INDP 11-04-2024
  • Dividend Yield
  • VRME N/A
  • INDP N/A
  • EPS Growth
  • VRME N/A
  • INDP N/A
  • EPS
  • VRME N/A
  • INDP N/A
  • Revenue
  • VRME $25,428,000.00
  • INDP N/A
  • Revenue This Year
  • VRME $1.14
  • INDP N/A
  • Revenue Next Year
  • VRME $10.56
  • INDP N/A
  • P/E Ratio
  • VRME N/A
  • INDP N/A
  • Revenue Growth
  • VRME N/A
  • INDP N/A
  • 52 Week Low
  • VRME $0.85
  • INDP $1.03
  • 52 Week High
  • VRME $2.45
  • INDP $3.25
  • Technical
  • Relative Strength Index (RSI)
  • VRME 56.99
  • INDP 36.19
  • Support Level
  • VRME $1.28
  • INDP $1.10
  • Resistance Level
  • VRME $1.43
  • INDP $1.22
  • Average True Range (ATR)
  • VRME 0.10
  • INDP 0.12
  • MACD
  • VRME -0.00
  • INDP 0.00
  • Stochastic Oscillator
  • VRME 72.00
  • INDP 24.00

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: